Monitor CTOR's bid price trajectory and any reverse stock split or other compliance measures the company may pursue before the April 2027 deadline. A delisting notice would likely trigger significant downside.
Price Chart
Executive Summary
Citius Oncology received a Nasdaq extension through April 19, 2027, to regain compliance with the $1.00 minimum bid price rule. The stock continues trading on Nasdaq under CTOR while the company evaluates options to meet the requirement.
Key Facts
- Nasdaq granted extension until April 19, 2027, to comply with Bid Price Rule 5550(a)(2)
- Compliance requires closing bid price at $1.00 or more for 10 consecutive business days
- Failure to regain compliance by deadline will trigger delisting notice, subject to appeal
- Stock continues trading on Nasdaq Capital Market under symbol CTOR during extension period
Financial Impact
Delisting risk with no specified financial penalty; potential loss of Nasdaq listing if compliance not achieved by April 19, 2027
Risk Factors
- Failure to regain compliance by April 19, 2027, could lead to delisting from Nasdaq
- Potential need for reverse stock split or other dilutive measures to boost share price
- Uncertainty around company's ability to maintain other Nasdaq listing requirements
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-112109 |
| Document: 0001213900-26-112109-index-headers.html | 0001213900-26-112109 |
| Document: 0001213900-26-112109-index.html | 0001213900-26-112109 |
| Document: 0001213900-26-112109.txt | 0001213900-26-112109 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $0.6000 | awaiting T+5 | — | $0.5800 (−3.33%) |
Oct 26, 2026 today | Press Release | $0.6072 | awaiting T+5 | — | $0.5800 (−4.48%) |
Oct 23, 2026 3d ago | 8-K | $0.5795 | awaiting T+5 | — | $0.5800 (−0.09%) |
Aug 12, 2026 10w ago | 8-K | $0.8115 $0.7525 | ▼ −7.27% | ▼ −6.83% | $0.5800 (−28.53%) |
Aug 5, 2026 11w ago | 8-K | $0.7850 $0.8115 | ▲ +3.38% | ▲ +3.03% | $0.5800 (−26.11%) |
Jun 8, 2026 20w ago | EFFECT | $0.7999 $0.6802 | ▲ +14.96% | ▲ +17.08% | $0.5800 (+27.49%) |
Jun 1, 2026 21w ago | 8-K | $0.7830 $0.7200 | ▼ −8.05% | ▼ −5.08% | $0.5800 (−25.93%) |
May 29, 2026 21w ago | S-3 | $0.7920 $0.7800 | ▲ +1.52% | ▼ −1.24% | $0.5800 (+26.77%) |
May 15, 2026 23w ago | 8-K | $0.8290 $0.8600 | ▲ +3.74% | ▲ +2.12% | $0.5800 (−30.04%) |
Mar 3, 2026 33w ago | EFFECT | $1.06 $1.01 | ▼ −5.19% | ▼ −4.71% | $0.5800 (−45.28%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers